methantheline has been researched along with Psoriasis in 1 studies
Methantheline: A quaternary ammonium compound that acts as an antimuscarinic agent. It has been used in the treatment of PEPTIC ULCER, in gastrointestinal disorders associated with smooth muscle spasm, and in the management of urinary incontinence, and may also be used for the treatment of HYPERHIDROSIS.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PERRY, DJ | 1 |
| MOUNT, GE | 1 |
| WRIGHT, ET | 1 |
1 other study available for methantheline and Psoriasis
| Article | Year |
|---|---|
STUDY OF GALVANIC SKIN RESPONSE IN PSORIASIS.
Topics: Atropine; Galvanic Skin Response; Humans; Methacholine Compounds; Methantheline; Pilocarpine; Psoria | 1963 |